Nestec S.a.

Societe Des Produits Nestle S.a.

Jean-Richard Neeser

Roberto Reniero

Alain Servin

Florence Rochat

Norbert Sprenger

Dominique Brassart

Bernhard Guggenheim

Kurt Eyer

Francesca Stingele

Corinne Lesens

Nicola D'Amico

Daniel Schmid

Dominique De Maleprade

Jerome Lemoine

Eduardo Schiffrin

Rafael Berrocal

Christian Darimont-Nicolau

Pierre Wursch

Katherine Mace

Harriet Link

Sandrine Gremlich

Olivier Mignot

Anne Donnet

Elena-Maria Comelli

J&uuml;rg Aebischer

Pier Sandro Cocconcelli

David Pridmore

Christoph Cavadini

Harald Bruessow

Thierry Von Der Weid

Pierre Tachon

Jurg Aebischer

Walter Gaier

Claude Parmantier

Pierre Michetti

Stephanie Blum-Speriesen

Bruno Pot

Raylene Reimer

Raylene Alison Reimer

Nicole Favre

Sebastien Vincent

Markus Brandt

Walter P Hammes

Sabine Waldbuesser

Patrice Desachy

Pier Sandro Istituto Di Microbiol Cocconcelli

Oligosaccharide mixtures consisting of at least one N-acetyl-lactosamine, at least one sialylated oligosaccharide, and at least one fucosylated oligosaccharide are provided. Food products, especially infant formula, comprising the oligosaccharide mixture are also provided.

Oligosaccharide mixture and food product comprising same

The invention discloses an oligosaccharide mixture comprising at least one N-acetyl-lactosamine, at least one sialylated oligosaccharide, and at least one fucosylated oligosaccharide. Food product, especially infant formula, comprising said oligosaccharide mixture.

Oligosaccharide mixture and food product comprising this mixture, especially infant formula

The invention discloses an oligosaccharide mixture comprising 5-70 wt % of at least one N-acetylated oligosaccharide, 5-90 wt % of at least one neutral oligosaccharide, 2-50 wt % of at least one sialylated oligosaccharide, and/or 5-70 wt % of at least one fucosylated oligosaccharide. The invention also discloses a food product, especially an infant formula, comprising said oligosaccharide mixture.

A milk protein hydrolysate which is preferably caseinoglycomacropeptide and/or a whey protein in a bioavailable form is used for the manufacture of a composition for the treatment or prevention of diabetes or syndrome X. The invention also relates to a method of treatment or prevention of diabetes or syndrome X utilizing such compositions, a method for assessing proglucagon gene expression and GLP-1 release by a cell line derived from an adenocarcinoma of human caecum.

Treatment of diabetes with milk protein hydrolysate

The present invention pertains to novel microorganisms of the genus, that are useful in preventing diarrhea brought about by pathogenic bacteria. In particular, the present invention relates to the use of said microorganisms for the preparation of an ingestable support and to a composition containing the same.

Bifidobacteria preventing diarrhea caused by pathogenic bacteria

A lactic bacteria strain that is exogenous to the oral microflora is selected for its ability to adhere the pellicle of the teeth and to produce a growth inhibition factor. This strain is used for the preparation of a composition intended for reducing dental plaque and for treating or preventing root caries and other diseases related toin mammals.

Treatment of actinomyces naeslundii-related diseases with exogenous lactic bacteria strains

The present invention provides compositions for the prophylaxis or treatment of dental caries, dental plaque, and periodontal infection that include lactic bacteria that are not part of the resident micriflora of the mouth, that are low acidifying, and that are capable of adhering directly to the pellicle of the teeth. Preferably, the lactic bacteria of the include one or more ofsubsp.orsubsp.The compositions are used in methods of treating or preventing dental caries, dental plaque, and periodontal infection.

Incorporation of exogenous lactic bacteria into the oral microflora

The present invention relates to an isolated and purified strain of the specieswhich produces levan. The present invention further relates to a method of producing the levan, and to a method of preparing various human or pet food products or cosmetic products which utilizes the levan and/or a strain producing the same.

Levan-producing Lactobacillus strain and method of preparing human or pet food products using the same

[object Object]

Novel microorganisms of the family Lactobacillaceae and pharmaceutical compositions, food and methods of using same are provided. The microorganisms have the ability of preventing colonization of the intestine with pathogenic bacteria causing diarrhea and of preventing infection of intestinal epithelial cells by. The microorganisms can be used for the preparation of an ingestable support and to compositions containing same.

Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses

The present invention pertains to novel microorganisms of the genus , that are useful in preventing diarrhoea brought about by pathogenic bacteria. In particular, the present invention relates to the use of said microorganisms for the preparation of an ingestable support and to a composition containing the same.

Lactobacillus paracasei strain for preventing diarrhea caused by pathogenic bacteria

The invention relates to a food composition containing an effective quantity of rennetted milk for preventing or treating dental caries or dental plaque. The invention also relates to a method of preparing the composition.

Anticariogenic dairy product and its use

Strain of lactic acid bacterium, (1) whose 16S ribosomal RNA is characteristic of the genus Streptococcus, (2) whose total protein profile, obtained after migration of the total proteins on an SDS-PAGE electrophoresis gel, is characteristic of that of the strain of lactic acid bacterium CNCM I-1920 but distinct from those of the recognized species belonging to the genus Streptococcus, namely ssp. ssp. ssp. ssp. . The invention also relates to the use of a strain of lactic acid bacterium according to the invention, or of a polysaccharide secreted by a strain according to the invention, for the preparation of a dietary composition, in particular an acidified milk or a fromage frais. The invention also relates to a dietary or pharmaceutical composition comprising a strain of lactic acid bacterium or a polysaccharide consisting of a succession of glucose, galactose and N-acetylglucosamine in a respective proportion of 3:2:1. In particular, strains CNCM I-1920, I-1921, I-1922, I-1923, I-1924, I-1925 and I-1926.

Lactic acid bacteria species

A food or cosmetic composition containing a dextran composition synthesized by a dextran sucrase enzyme produced by a strain of,ssp.,. The food or cosmetic composition is prepared by fermenting a food or cosmetic composition containing sucrose with the strain, or the strain is cultured in a culture medium containing sucrose and the dextran composition produced is incorporated into a food or cosmetic substance.

Products containing a dextran composition obtained from culturing Leuconostoc mesenteroidesssp. cremoris

Growing community of inventors

Savigny, Switzerland

Jean-Richard Neeser